FAS and lip and oral cavity carcinoma: Suberoylanilide hydroxamic acid (SAHA) markedly enhanced the expressions of DR4, DR5, Fas cell surface death receptor (Fas), and the Fas ligand (FasL; FASLG) in oral cancer Ca9-22 and SAS cells [16].